Pfizer CEO Profits After COVID Vaccine Announcement

MarketScale
MarketScale
Nov 30, 2020
Albert Bourla CEO Coronavirus COVID Daniel Litwin Podcast Moderna Pfizer profit shareholders Stock Tyler Kern Podcast Vaccine

Eyebrows raised when Pfizer CEO sold some of his holdings in the company to the tune of $5.6 million. The prescheduled sale came at the perfect time, when the company publicly announced promising results from early COVID vaccine trials. CNBC reports that Bourla’s base salary was $1.65 million in April. After his most recent sale of shares, he still owns nine times his salary in shares, approximately $15 million.

MarketScale Radio hosts Daniel Litwin and Tyler Kern dissect the news. Litwin considers the serendipity of the sale timed with the public announcement. Kern and Litwin consider the thought of one person profiting tremendously off of a public good like a life-saving vaccine, and in the end, Kern points out, any one takeaway depends on how one feels about capitalism’s economic structures and incentives.

KEY POINTS:

  • Pfizer CEO Albert Bourla sells $5.6 million worth of stock just as it jumps 15%.
  • The sale was pre-scheduled, but opportunely timed with the public announcement of a promising vaccine.
  • Other medical executives at Moderna also are cashing in on spiking stocks while vaccines inch toward approval.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

partnership
CG Infinity’s Salesforce Practice Excels When Partnership Drives Outcomes
January 31, 2026

Meaningful work often comes from shared success, where customer outcomes and team outcomes are closely connected. At CG Infinity, this mindset shapes how client relationships are approached—not as transactions, but as partnerships built on collaboration, trust, and mutual accountability. The focus goes beyond delivering a solution to working side by side with customers, exchanging ideas,…

Read More
CG Infinity
CG Infinity’s Salesforce Practice: Built for Adoption, Execution, and Results
January 31, 2026

Pooja Arya, VP of Delivery and Technical Solutions Leader at CG Infinity, reflects on a recent Salesforce engagement that exemplified what meaningful delivery looks like when execution, alignment, and outcomes come together. The project involved a full Salesforce implementation spanning Sales Cloud, Service Cloud, and Marketing Cloud, and was delivered on time despite significant technical…

Read More
Salesforce practice
How CG Infinity’s Salesforce Practice Delivers Measurable Client Impact
January 31, 2026

CG Infinity’s Salesforce practice focuses on delivering clarity, discipline, and real outcomes—helping clients avoid unnecessary spend while building only what truly drives value. With deep expertise across Marketing Cloud, Sales Cloud, and Service Cloud, CG Infinity partners closely with clients to deliver focused, high-impact solutions that make a measurable difference. Jeff Abernathy, VP of…

Read More
team
How Rapid Response Consulting Turned Team Misalignment Into Forward Motion
January 30, 2026

When organizations hit critical pressure points—missed timelines, overloaded teams, or stalled initiatives—Rapid Response Consulting provides immediate reinforcement to stabilize operations and restore momentum. At CG Infinity, rapid response isn’t just about deploying expertise quickly; it’s about integrating with intention, protecting delivery, and reducing friction when stakes are high. That philosophy is reflected in the experience…

Read More
Related
survey
Software & Technology
Survey Ready Every Day: Why It’s Not Just a Once-a-Year Activity
January 13, 2026
Dr. G. Duncan Finlay
Healthcare
The Legacy of Dr. G. Duncan Finlay – Episode 6
January 9, 2026

The Rothman Index, developed by Dr. Michael Rothman and his brother Steven, is a pioneering patient acuity score designed to help clinicians recognize patient deterioration earlier and more clearly. Presented as an easily understood, color-coded graph that updates in real time, the Index displays upward and downward trends in patient condition at a glance—transforming…

Read More
Rothman Index
Healthcare
The Origin Story of the Rothman Index – Episode 5
January 8, 2026

Hospitals collect enormous amounts of clinical data, yet preventable patient decline remains a persistent challenge. Over the past two decades, hospitals have invested heavily in early warning scores and rapid response infrastructure, but translating data into timely, meaningful action has proven difficult. As clinicians contend with alert fatigue and increasing documentation burden, a more…

Read More